The consistent positive outcomes from these clinical trials and supported research provide strong evidence for the efficacy of Semaglutide in weight management and its potential to revolutionize diabetes treatment
Now, it's going a step further by launching a program that can prescribe a new generation of weight-loss drugs that have gained in popularity
These products have different concentrations and approved indications
Covariates Baseline covariates included age, sex, race, ethnicity, geographic region, index year, T2D history, payer type, prescribers specialty, Charlson Comorbidity Index (CCI) [24, 25], diabetes complication severity index (DCSI) [26, 27], body mass index (BMI), and number of all distinct prescription drugs